|
EP0038154B1
(en)
|
1980-04-15 |
1983-09-21 |
Beecham Group Plc |
Allergens modified with polysarcosines
|
|
US5204096A
(en)
|
1984-03-07 |
1993-04-20 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
|
US4722840A
(en)
|
1984-09-12 |
1988-02-02 |
Chiron Corporation |
Hybrid particle immunogens
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
JPH01501064A
(ja)
|
1986-09-22 |
1989-04-13 |
エモリ ユニバーシティ |
ワクチンとその製法
|
|
US5143726A
(en)
|
1986-12-09 |
1992-09-01 |
The Scripps Research Institute |
T cell epitopes of the hepatitis B virus nucleocapsid protein
|
|
GB8903313D0
(en)
|
1989-02-14 |
1989-04-05 |
Wellcome Found |
Conjugates
|
|
GB8913737D0
(en)
|
1989-06-15 |
1989-08-02 |
Univ Birmingham |
A novel anti-allergy treatment
|
|
US5178882A
(en)
|
1990-06-22 |
1993-01-12 |
The Regents Of The University Of California |
Viral decoy vaccine
|
|
US5334394A
(en)
|
1990-06-22 |
1994-08-02 |
The Regents Of The University Of California |
Human immunodeficiency virus decoy
|
|
US5142726A
(en)
*
|
1991-04-03 |
1992-09-01 |
Mann Robert F |
Adjustable bristle length toothbrush
|
|
GB9114003D0
(en)
|
1991-06-28 |
1991-08-14 |
Mastico Robert A |
Chimaeric protein
|
|
ZA934199B
(en)
|
1992-06-18 |
1994-01-10 |
Akzo Nv |
Carrier system against gnrh
|
|
US6004763A
(en)
|
1992-09-11 |
1999-12-21 |
Institut Pasteur |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
|
|
JP3265577B2
(ja)
*
|
1992-10-13 |
2002-03-11 |
デューク・ユニバーシティ |
アポリポ蛋白ｅの４型イソ型の測定法
|
|
EP0678034B1
(en)
|
1993-01-11 |
1999-05-26 |
Dana Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US6180771B1
(en)
|
1993-12-08 |
2001-01-30 |
Immulogic Pharmaceutical Corp. |
Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
|
|
US5935821A
(en)
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
JPH09202735A
(ja)
|
1996-01-25 |
1997-08-05 |
Nof Corp |
リポソーム型アレルギー治療薬
|
|
US5786161A
(en)
|
1996-06-06 |
1998-07-28 |
Miltenyi Biotec. Gmbh |
Isolation and characterization of allergen-binding cells for diagnosis of hypersensitivity
|
|
SE9604815D0
(sv)
|
1996-12-20 |
1996-12-20 |
Pharmacia & Upjohn Ab |
A metod of diagnosis
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP2006303A1
(en)
|
1997-04-09 |
2008-12-24 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US6054312A
(en)
|
1997-08-29 |
2000-04-25 |
Selective Genetics, Inc. |
Receptor-mediated gene delivery using bacteriophage vectors
|
|
US6905686B1
(en)
*
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
EP1033998B1
(en)
|
1997-12-03 |
2005-10-19 |
Neuralab, Ltd. |
Suppressing beta-amyloid-related changes in alzheimer's disease
|
|
WO1999040934A1
(en)
|
1998-02-12 |
1999-08-19 |
Immune Complex, Corporation |
Strategically modified hepatitis b core proteins and their derivatives
|
|
US5990085A
(en)
|
1998-05-04 |
1999-11-23 |
Michigan State University |
Inhibin-HBc fusion protein
|
|
ATE314095T1
(de)
|
1998-10-21 |
2006-01-15 |
Us Health |
Virusähnliche partikel zur induktion von autoantikörpern
|
|
US6380364B1
(en)
|
1998-11-23 |
2002-04-30 |
Loyola University Of Chicago |
Chimeric biotin-binding papillomavirus protein
|
|
NZ512456A
(en)
|
1998-11-30 |
2003-10-31 |
Cytos Biotechnology Ag |
Ordered molecular presentation of antigens
|
|
EA004497B1
(ru)
|
1998-12-04 |
2004-04-29 |
Байоджен, Инк. |
Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
|
|
CN1520423A
(zh)
|
1999-02-25 |
2004-08-11 |
ʷ��˿�������ȳ�ķ����˾ |
来源于IgE的Cε3或Cε4区的抗原决定基或拟表位,其拮抗物,及其治疗用途
|
|
JP2003509020A
(ja)
|
1999-09-03 |
2003-03-11 |
ラモット・ユニバーシティ・オーソリティ・フォー・アプライド・リサーチ・アンド・インダストリアル・ディベロップメント・リミテッド |
プラーク形成疾患の診断、治療、予防に有用な薬剤、組成物、その使用法
|
|
US20020052311A1
(en)
|
1999-09-03 |
2002-05-02 |
Beka Solomon |
Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
|
|
WO2001053457A2
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Vaccines against neurodegenerative disorders
|
|
ES2248283T3
(es)
|
2000-02-21 |
2006-03-16 |
Pharmexa A/S |
Nuevo procedimiento para reducir los niveles de amiloide.
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
US8519005B2
(en)
*
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US7094409B2
(en)
|
2001-01-19 |
2006-08-22 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of allergic eosinophilic diseases
|
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
JP4360906B2
(ja)
|
2001-09-14 |
2009-11-11 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
|
|
US7115266B2
(en)
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
US20030219459A1
(en)
|
2002-01-18 |
2003-11-27 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
|
EP2351770A1
(en)
|
2002-07-17 |
2011-08-03 |
Cytos Biotechnology AG |
Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
MXPA04011247A
(es)
|
2002-07-19 |
2005-02-17 |
Cytos Biotechnology Ag |
Conjugados portadores de grelina.
|
|
SI1524994T1
(sl)
*
|
2002-07-19 |
2011-08-31 |
Cytos Biotechnology Ag |
Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
|
|
WO2004016262A1
(ja)
|
2002-08-12 |
2004-02-26 |
Kyowa Hakko Kogyo Co., Ltd. |
アミノ酸含有チュアブル錠
|
|
TW200509968A
(en)
*
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
|
TW200501962A
(en)
*
|
2003-04-01 |
2005-01-16 |
Novartis Ag |
Use of carbamazepine derivatives for the treatment of agitation in dementia patients
|
|
GB0424563D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|